Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22569804 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Cancer;   Pancreatic Cancer
Interventions: Drug: IMMU-107;   Drug: placebo;   Drug: Gemcitabine

Study has passed its completion date and status has not been verified in more than two years.